Skip to main content

Advertisement

Table 1 Clinico-pathological features of the study cohort

From: Validity of St Gallen risk categories in prognostication of breast cancer patients in Southern Sri Lanka

Clinico-pathological features n(%) Clinico-pathological features n(%)
Tumour size   TNM stage  
  < 20 mm 219 (30.7) Stage I 133(18.6)
  > 20-50 mm 425 (59.6) Stage II 341(47.8)
  > 50 mm 55 (7.7) Stage III 225(31.5)
 Unknown 14 (1.9) Stage IV 5(0.7)
Nottingham grade   Unknown 09(1.2)
 Grade 1 71(10)   
 Grade 2 279(39.1) Expression of ER
 Grade 3 291(40.8) Positive 241(33.8)
 Unknown 72a(10) Negative 409(57.4)
Lymph node stage   Unknown 63a(8.8)
 Stage 0 336(47.1)   
 Stage 1 163(22.8) Expression of PgR
 Stage 2 134(18.8) Positive 259(36.3)
 Stage 3 80(11.2) Negative 386(54.1)
   Unknown 68a(9.5)
Lympho-vascular invasion    
 Presence 218(30.5) Expression of HER2  
 Absence 494(69.5) Positive 133(18.6)
 Unknown 01(0.1) Negative 484(67.9)
   Unknown 96a(13.5)
  1. n number, % percentage, ER oestrogen receptor, PgR progesterone receptor, HER2 human epidermal growth factor receptor2
  2. a Grade, ER, PgR and HER2 could not be assessed as the archival slides and tissue were poorly preserved